Mark Bonyhadi
Director/Board Member at TC BIOPHARM (HOLDINGS) PLC
Net worth: - $ as of 2023-11-29
Profile
Mark L.
Bonyhadi is currently an Independent Director at TC Biopharm (Holdings) Plc since 2022 and a Senior Advisor at Qiming US Ventures Management, LLC since 2018.
Previously, he served as the Chairman of the American Society of Gene & Cell Therapy.
From 2006 to 2013, he was the Director-Global Business Development at Life Technologies Ltd.
Prior to that, he held the position of Vice President-Research & Development at Xcyte Therapies, Inc. from 1997 to 2006.
From 2013 to 2018, he worked as the Vice President-Research & Head-Academic Affairs at Juno Therapeutics, Inc. He also worked as a Senior Scientist at Systemix, Inc. Dr. Bonyhadi completed his undergraduate degree at The Reed Institute in 1982 and obtained his doctorate degree from the University of California, Berkeley in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-05 | 0 ( -.--% ) | - $ | 2023-11-29 |
Mark Bonyhadi active positions
| Companies | Position | Start |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Director/Board Member | 2022-02-21 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | 2018-11-30 |
Former positions of Mark Bonyhadi
| Companies | Position | End |
|---|---|---|
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Chief Tech/Sci/R&D Officer | 2021-10-11 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 2017-12-31 |
Life Technologies Ltd.
 Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Corporate Officer/Principal | 2012-12-31 |
| Xcyte Therapies, Inc. | Chief Tech/Sci/R&D Officer | 2006-03-29 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Chairman | - |
Training of Mark Bonyhadi
| The Reed Institute | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 6 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
| Xcyte Therapies, Inc. | Health Technology |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Stock Market
- Insiders
- Mark Bonyhadi